story of the week
Effects of SGLT2 Inhibitor Use on the Incidence of New-Onset Diabetes Among Patients With Cardiovascular or Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
Eur Heart J 2024 Nov 21;[EPub Ahead of Print], JW Ostrominski, MC Højbjerg Lassen, BL Claggett, ZM Miao, SE Inzucchi, KF Docherty, AS Desai, PS Jhund, L Køber, P Ponikowski, MS Sabatine, CSP Lam, FA Martinez, RA de Boer, AF Hernandez, SJ Shah, M Petersson, AM Langkilde, JJV McMurray, SD Solomon, M VaduganathanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.